Prevalence of complications and co‐morbidities in males and females with obesity: Real‐world insights from claims data analysis
Open Access
- 11 September 2024
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 26 (11) , 5005-5012
Abstract
Aim: To comprehensively examine the range of co‐morbidities among males and females with a diagnosis of obesity. Materials and Methods: This cross‐sectional retrospective study used US commercial and Medicare claims data from Merative MarketScan Research Databases to identify adults (age ≥ 18 years) with a diagnosis of obesity with continuous insurance coverage from 2018 to 2020. Co‐morbidities were tabulated based on coded diagnoses, and prevalences were calculated in males and females across age groups. Age‐adjusted odds ratios (ORs) determined differences in co‐morbidities between the sexes. Results: Of an eligible sample of 6.9 million, we identified 2 028 273 individuals with at least one obesity‐related International Classification of Diseases, 10th Revision, Clinical Modification code. The proportions of males and females with obesity were 43.0% versus 57.0%. The most prevalent co‐morbidities among males and females were hypertension (62.8% vs. 52.2%), dyslipidaemia (63.3% vs. 50.3%) and depression and/or anxiety (D/A; 29.7% vs. 48.5%). The prevalence of D/A was high in the younger age group, but steadily decreased with age in both sexes; however, hypertension and dyslipidaemia continued to increase with age. The presence of diagnosis of hypertension and dyslipidaemia was 6‐8 years earlier in males than in females. Females had higher odds than males for osteoarthritis (OR 1.33), depression (OR 2.22) or osteoporosis (OR 7.10); all P < .0001. Conclusions: Males with obesity received a diagnosis of cardiovascular risk factors at an earlier age than females, which may have contributed to the higher prevalence of coronary heart disease. Understanding sex‐specific variations in co‐morbidities across ages can support early screening and diagnosis of risk clusters for optimal obesity management.Keywords
Funding Information
- Eli Lilly and Company
This publication has 34 references indexed in Scilit:
- The relationship between internalized weight stigma and physical and mental health-related quality of life in a large sample of women: a structural equation modeling analysisEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2023
- Explaining adult obesity, severe obesity, and BMI: Five decades of changeHeliyon, 2023
- Global Burden of osteoarthritis associated with high body mass index in 204 countries and territories, 1990–2019: findings from the Global Burden of Disease Study 2019Endocrine, 2022
- Sex Differences in Cardiovascular Consequences of Hypertension, Obesity, and DiabetesJACC, 2022
- Association of Body Mass Index in Midlife With Morbidity Burden in Older Adulthood and LongevityJAMA Network Open, 2022
- Sex/Gender Differences in Obesity Prevalence, Comorbidities, and TreatmentCurrent Obesity Reports, 2021
- Obstructive Sleep Apnea in Obese Patients: a UK Population AnalysisObesity Surgery, 2021
- Lifestyle Modifications for Preventing and Treating Heart FailureJACC, 2018
- Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of MorbidityJAMA Cardiology, 2018
- Is there a bi-directional relationship between depression and obesity among adult men and women? Systematic review and bias-adjusted meta analysisAsian Journal of Psychiatry, 2016